Antibiotics - The Perfect Storm

We need new antibiotics to fight infections caused by resistant bacteria. But the marketplace, the structure of the pharmaceutical industry, regulatory agencies, and difficult science are conspiring to deny us the products we need. This blog will present perspectives and developments in the fight for new antibiotics.

Friday, March 26, 2010

IDSA 10, USA 0.

I thought that this would be an appropriate title for a blog during March Madness (which I do not follow at all). I recently attended a Gor...

Thursday, March 18, 2010

EARTHQUAKE!

The FDA has just set off what could be an earthquake of 9.5 on the Richter scale! This apparently came to pass during discussions bet...

Sunday, March 7, 2010

“Just say no” vs. “The Champion”

In the pharmaceutical industry, it is always (almost) less costly to say no. It is also more costly to continue a program that is almost ...

Monday, March 1, 2010

Innovation in Biotech?

In examining the late stage pipeline for antibiotics in biotech, I have been disappointed. Antimicrobial Compounds in Development ...

In examining the late stage pipeline for antibiotics in biotech, I have been disappointed. In this table, the Ph. II or later stage ...

Friday, February 12, 2010

Pharmaceutical Companies are Chicken

Actually, this is not a blog about the use of antibiotics and hormones in poultry. It is about the pharmaceutical industry’s risk averse ap...

Monday, February 1, 2010

Generic Antibiotics: Effective and Safe?

Today I am going back to the FDA’s Advisory Committee (AIDAC) meeting on a new antibiotic, telithromycin (Ketek), in December, 2006. Telith...

View web version

Powered by Blogger.